Crystalline And Amorphous Forms Of A Beta-Arrestin Effector

The present disclosure provides novel crystalline forms of a compound that acts as a β-arrestin effector, processes for preparing novel crystalline and amorphous forms of a compound that acts as a β-arrestin effector and uses thereof.

Saved in:
Bibliographic Details
Main Authors Sanghvi Ritesh, Kalyan Yuriy B, Ronsheim Matthew, Zhou Shao Hong, Lawton Graham Richard, Yu Meiki, Alcorn Gregory, Tian Jiaher
Format Patent
LanguageEnglish
Published 05.10.2017
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides novel crystalline forms of a compound that acts as a β-arrestin effector, processes for preparing novel crystalline and amorphous forms of a compound that acts as a β-arrestin effector and uses thereof.
Bibliography:Application Number: US201615345234